181 related articles for article (PubMed ID: 24619404)
1. Hyperthermia generated with ferucarbotran (Resovist®) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells.
Sato I; Umemura M; Mitsudo K; Kioi M; Nakashima H; Iwai T; Feng X; Oda K; Miyajima A; Makino A; Iwai M; Fujita T; Yokoyama U; Okumura S; Sato M; Eguchi H; Tohnai I; Ishikawa Y
J Physiol Sci; 2014 May; 64(3):177-83. PubMed ID: 24619404
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles.
Kalber TL; Ordidge KL; Southern P; Loebinger MR; Kyrtatos PG; Pankhurst QA; Lythgoe MF; Janes SM
Int J Nanomedicine; 2016; 11():1973-83. PubMed ID: 27274229
[TBL] [Abstract][Full Text] [Related]
3. The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model.
Jeon MJ; Ahn CH; Kim H; Chung IJ; Jung S; Kim YH; Youn H; Chung JW; Kim YI
J Exp Clin Cancer Res; 2014 Jul; 33(1):57. PubMed ID: 25037747
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo.
Oba M; Yano S; Shuto T; Suico MA; Eguma A; Kai H
Int J Oncol; 2008 Jun; 32(6):1317-24. PubMed ID: 18497994
[TBL] [Abstract][Full Text] [Related]
5. Simulation and experimental studies on magnetic hyperthermia with use of superparamagnetic iron oxide nanoparticles.
Murase K; Oonoki J; Takata H; Song R; Angraini A; Ausanai P; Matsushita T
Radiol Phys Technol; 2011 Jul; 4(2):194-202. PubMed ID: 21667079
[TBL] [Abstract][Full Text] [Related]
6. CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field.
Su Z; Liu D; Chen L; Zhang J; Ru L; Chen Z; Gao Z; Wang X
Int J Nanomedicine; 2019; 14():7549-7560. PubMed ID: 31571863
[TBL] [Abstract][Full Text] [Related]
7. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model.
Matsumi Y; Kagawa T; Yano S; Tazawa H; Shigeyasu K; Takeda S; Ohara T; Aono H; Hoffman RM; Fujiwara T; Kishimoto H
Cell Cycle; 2021 Jun; 20(12):1122-1133. PubMed ID: 34110969
[TBL] [Abstract][Full Text] [Related]
9. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
[TBL] [Abstract][Full Text] [Related]
11. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
[TBL] [Abstract][Full Text] [Related]
12. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
13. A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.
Alhazzazi TY; Kamarajan P; Xu Y; Ai T; Chen L; Verdin E; Kapila YL
Anticancer Res; 2016 Jan; 36(1):49-60. PubMed ID: 26722027
[TBL] [Abstract][Full Text] [Related]
14. Contribution of a 300 kHz alternating magnetic field on magnetic hyperthermia treatment of HepG2 cells.
Wang X; Chen Y; Huang C; Wang X; Zhao L; Zhang X; Tang J
Bioelectromagnetics; 2013 Feb; 34(2):95-103. PubMed ID: 23059525
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of cell killing by induction of apoptosis after treatment with mild hyperthermia at 42 degrees C and cisplatin.
Ohtsubo T; Igawa H; Saito T; Matsumoto H; Park H; Song CW; Kano E; Saito H
Radiat Res; 2001 Jul; 156(1):103-9. PubMed ID: 11418078
[TBL] [Abstract][Full Text] [Related]
16. Application of biocompatible and ultrastable superparamagnetic iron(III) oxide nanoparticles doped with magnesium for efficient magnetic fluid hyperthermia in lung cancer cells.
Nowicka AM; Ruzycka-Ayoush M; Kasprzak A; Kowalczyk A; Bamburowicz-Klimkowska M; Sikorska M; Sobczak K; Donten M; Ruszczynska A; Nowakowska J; Grudzinski IP
J Mater Chem B; 2023 May; 11(18):4028-4041. PubMed ID: 36960952
[TBL] [Abstract][Full Text] [Related]
17. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
Roh JL; Park JY; Kim EH; Jang HJ
Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome.
Ray S; Cheng CA; Chen W; Li Z; Zink JI; Lin YY
Nanotheranostics; 2019; 3(2):166-178. PubMed ID: 31183312
[No Abstract] [Full Text] [Related]
19. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
Jiang M; Liu Z; Xiang Y; Ma H; Liu S; Liu Y; Zheng D
BMC Cancer; 2011 Feb; 11():54. PubMed ID: 21291526
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous hyperthermia-chemotherapy with controlled drug delivery using single-drug nanoparticles.
Sato I; Umemura M; Mitsudo K; Fukumura H; Kim JH; Hoshino Y; Nakashima H; Kioi M; Nakakaji R; Sato M; Fujita T; Yokoyama U; Okumura S; Oshiro H; Eguchi H; Tohnai I; Ishikawa Y
Sci Rep; 2016 Apr; 6():24629. PubMed ID: 27103308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
